Company profile
Frontage Holdings Corporation
OTC: FGHQF · Healthcare · Biotechnology
#270 of 1,418 Healthcare companies by revenue44th-percentile growth
EA Score
72BFH 80DQ —GM 53SS 64
v0.1 · 45/100 weight · provisional
↑ Piotroski F, workforce scale · ↓ listing tenure, 3-yr revenue growth
Methodology →Revenue TTM
$512.1M
Rev growth YoY (TTM)
+0.3%
Net income (FY)
$6.8M
Employees
1,523
as of 2026-08-13
Market cap
$304.2M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$257.1M$257.1M2025
Net income$6.8M$6.8M2025
Operating income$14.6M$14.6M2025
Total assets$541.0M$541.0M2025
Liabilities$191.0M$191.0M2025
Equity$346.7M$346.7M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Frontage Holdings Corporation’s revenue?
Frontage Holdings Corporation booked $257.1M in FY2025 revenue, growing 0.8% year over year — about the middle of the pack among Healthcare companies we track, at a 2.6% net margin.
Peers · Healthcare
TerrAscend Corp.55COmada Health62CMedical Facilities Corporation74BLeMaitre Vascular, Inc.80B+American Well Corporation60CMesa Laboratories, Inc.78B+Neighbors
Chester →Key facts
CEOZhongping Lin
SectorHealthcare
IndustryBiotechnology
HeadquartersExton, PA
ExchangeOTC: FGHQF
Employees1,523
IPO date2020-04-14
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.